This research report analyzes the prevalent stem cell technologies and the therapeutic areas in which stem cells find their applications. The research study provides a market insight into the ever progressing and debatable market of Stem Cell Research segmented by type, technology and therapeutic area. Stem Cells by Type are further classified into Adult Stem Cells, Embryonic Stem Cells, and Cord Blood Stem Cells. Stem Cell Research by Technology is segmented into Stem Cell Transplantation, Cell Based Genomics, Xenotransplantation, Cord Blood Banking, and Other. The Therapeutic applications of Stem Cell Research are analyzed by area into Neurology, Bone and Cartilage, Cancer, Hematology, Cardiology, Diabetes, and Other.

Projections and estimates are graphically illustrated by geographic regions encompassing North America, Europe, Asia-Pacific, and Rest of World. Business profiles of 61 major companies are discussed in the research report. The research report serves as a guide to global Stem Cell industry covering 458 companies that are engaged in stem cell R&D, storage, banking, discovery, testing and supply of products and services. Major Contract Research Organizations and Universities serving the industry are also covered in the Corporate Directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, mergers and acquisitions, ethical issues, regulatory affairs, and other areas of concern is also covered in the research report. Exclusive graphical representations are provided for 149 exhibits.

Free Sample Research Report

Download Table of contents

The science of stem cells is leading to evolution of cell-based therapies referred to as reparative or regenerative medicine for the treatment of diseases. The ongoing research on stem cells indicates the replenishment of damaged cells by healthy cells in adult organism and the origin of an organism through a single cell. Stem cell science is predicted to be the most promising field in Biology though it has its own share of queries and controversies.

This report analyzes the prevalent stem cell technologies and the therapeutic areas in which stem cells find their applications. Global stem cells market is segmented by - Stem Cell Types into Adult Stem Cells, Embryonic Stem Cells and Cord Blood Stem Cells; by Therapeutic Area into Neurological, Bon and Cartilage, Cancer, Hematology, Cardiology, Diabetes and Other; and by Technology into SC Transplantation, CB Genomics, Xenotransplantation, Cord Blood Banking and Other.

Global Stem Cells market is projected to reach about US$26.3 billion by 2011. United States is the largest market for stem cells with an estimated share of 48.9% in 2006. Stem cell research has picked up pace like never before now. The technology is leading to a new kind of cell-based medicine that is regenerative in nature. However, practicality and ethics dominate the ever controversial subject. Hence, it may take some more time, before a proper worldwide consensus emerges on the usage and procedures of stem cell research. While some countries approve, some oppose. Stem cell research is most likely to gather pace in countries with less regulatory controls. Of all the countries, China has the most favorable environment for research. The UK too has a strong research presence. The United States is the leader in stem cell research. However, the government controls the grants for research but places no restrictions on funds from private, state, or local government resources.

Adult stem cells market is the largest tapped market while cord blood and embryonic stem cell markets, though with huge market potential, are still in infancy stages. The US is the leader followed by the European and Asia-Pacific regions. With government regulations being amended in several countries, stem cell research is expected to pick up pace rapidly in the next few years. The potential of stem cell research – both medically and economically, is leading to huge investments by biotechnology companies, pharmaceutical companies and governments too.

-Aastrom Biosciences, Inc. (USA)
-Advanced Cell Technology, Inc. (USA)
-ALDAGEN, Inc. (USA)
-Angel BioTechnology (UK)
-Axordia (UK)
-BioE (USA)
-Boehringer-Ingelheim GmbH (Germany)
-BrainStorm Cell Therapeutics, Inc. (USA)
-Cellartis AB (Sweden)
-Cellerix SL (Spain)
-Cellerant Therapeutics, Inc. (USA)
-CellsLife Ltd. (UK)
-Cellular Dynamics International (USA)
-Ceregene, Inc (USA)
-CordLife Ltd (Australia)
-CryoGENESIS International Ltd (UK)
-Cryo-Cell International, Inc. (USA)
-Cryo-Save AG (Switzerland)
-Cytori Therapeutics, Inc. (USA)
-Epistem Ltd. (UK)
-ES Cell International (Singapore)
-Gamida Cell Ltd. (Israel)
-GE Healthcare (UK)
-Genentech, Inc. (USA)
-Geron Corporation (USA)
-Intercytex (UK)
-Invitrogen Corp. (USA)
-LifeCell Corp. (USA)
-LifebankUSA (USA)
-Lazaron Biotechnologies SA (South Africa)
-Millipore Corp. (USA)
-MaxCyte, Inc. (USA)
-Mesoblast Ltd. (Australia)
-MultiCell Technologies, Inc. (USA)
-NeuroGeneration (USA)
-Novartis AG (Switzerland)
-NovaThera Ltd (UK)
-Novocell, Inc. (USA)
-Novo Nordisk A/B (Denmark)
-NsGene A/S (Denmark)
-Osiris Therapeutics, Inc. (USA)
-RegenTec (UK)
-ReInnervate (UK)
-Reliance Life Sciences (India)
-ReNeuron Group plc (UK)
-RhinoCyte, Inc. (USA)
-Sanofi-Aventis (France)
-SinoCells Bio Technologies Co., Ltd. (China)
-Stem cell Innovation (USA)
-Stem cell Sciences KK (Japan)
-Stem cell Sciences Ltd. (UK)
-Stem Cell Therapeutics Corp. (Canada)
-StemCell Technologies Inc. (USA)
-StemCells Inc. (USA)
-Stem Cell Technology Company (Iran)
-Takara Bio, Inc. (Japan)
-Titan Pharmaceuticals, Inc. (USA)
-TTP Labtech Ltd. (UK)
-Vesta Therapeutics Inc. (USA)
-ViaCell, Inc. (USA)
-VistaGen Therapeutics Inc. (USA)

For those who are intrested to buy the report by chapter:

CHAPTER	TITLE	SHORT DESCRIPTION	PRICE (US$)
I	Scope and Methodology	This chapter provides information regarding the research methodology, limitations of the study, market measuring units and exchange rates used. * Will be delivered free with purchase of any of the other chapters mentioned below.	FREE*
II	Report Synopsis	Synopsis of the report summarizes the global market of, Stem Cell Research by type, technology and therapeutic area. Global market is also analyzed by geographic regions including North America, Europe , Asia-Pacific and Rest of World. The chapter provides the market share values in percentage for each geographic region by country along with the market values. Global leading players are discussed.	$1250
III	Product / Technology Research	This chapter gives an insight into Stem Cell Research market including definitions, segmentation and applications. The chapter also provides market values in US$ (for the period 2005 through 2012) by type, technology, and therapeutic area for stem cell applications. Global and regional markets are analyzed. The chapter also includes product trends, potential opportunities, and several ethical issues and regulatory rules by country.	$1000
IV	Market Dynamics	Market Dynamics provides information on global markets for Stem Cell Research. The chapter includes global market analysis by geographic regions; analysis of each region by type, technology and therapeutic segments; a brief business profile of major global companies; and a glance at corporate activities such as mergers and acquisitions, partnerships, new product developments/launches etc. Also includes market trends and industry outlook.	$2200
V	Corporate Directory	This chapter provides the region-wise list of 521 companies, CROs, blood banks and academic institutions that are engaged in Stem Cell Research products and services market.	$350